First Header Logo Second Header Logo

Connection

Kathryn Greven to Cyclooxygenase 2 Inhibitors

Back to Details
This is a "connection" page, showing publications Kathryn Greven has written about Cyclooxygenase 2 Inhibitors.
Kathryn Greven
Connection Strength
0.252
Cyclooxygenase 2 Inhibitors
  1. Gaffney DK, Winter K, Dicker AP, Miller B, Eifel PJ, Ryu J, Avizonis V, Fromm M, Greven K. A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128. Int J Radiat Oncol Biol Phys. 2007 Jan 01; 67(1):104-9.
    View in: PubMed
    Score: 0.252
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.